Cardlytics Inc. (CDLX)’s liquidity ratios and what they mean


The price of Cardlytics Inc. (NASDAQ: CDLX) closed at $16.34 in the last session, down -14.67% from day before closing price of $19.15. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 988771 shares were traded. CDLX stock price reached its highest trading level at $19.01 during the session, while it also had its lowest trading level at $16.27.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.



We take a closer look at CDLX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 1.09 whereas as Long-Term Debt/Eq ratio is at 0.96.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on September 08, 2022, Downgraded its rating to Underweight and sets its target price to $13 from $14 previously.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 08 when Temsamani Karim Saad sold 81,542 shares for $17.71 per share. The transaction valued at 1,444,027 led to the insider holds 193,768 shares of the business.

Temsamani Karim Saad sold 85,431 shares of CDLX for $1,444,040 on Sep 07. The Chief Executive Officer now owns 275,310 shares after completing the transaction at $16.90 per share. On Aug 09, another insider, Lynton Nicholas Hollmeyer, who serves as the Chief Legal & Privacy Officer of the company, sold 7,500 shares for $13.67 each. As a result, the insider received 102,525 and left with 29,486 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 616.41M and an Enterprise Value of 786.55M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.08 while its Price-to-Book (P/B) ratio in mrq is 2.41. Its current Enterprise Value per Revenue stands at 2.60 whereas that against EBITDA is -1.95.

Stock Price History:

Over the past 52 weeks, CDLX has reached a high of $19.57, while it has fallen to a 52-week low of $2.57. The 50-Day Moving Average of the stock is 13.15, while the 200-Day Moving Average is calculated to be 7.46.

Shares Statistics:

According to the various share statistics, CDLX traded on average about 709.59K shares per day over the past 3-months and 646.57k shares per day over the past 10 days. A total of 37.72M shares are outstanding, with a floating share count of 36.46M. Insiders hold about 2.10% of the company’s shares, while institutions hold 95.80% stake in the company. Shares short for CDLX as of Aug 30, 2023 were 2.9M with a Short Ratio of 2.90M, compared to 3.23M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.69% and a Short% of Float of 8.96%.

Earnings Estimates

The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.01 for the current quarter, with a high estimate of -$0.01 and a low estimate of -$0.01, while EPS last year was -$0.5. The consensus estimate for the next quarter is $0.19, with high estimates of $0.19 and low estimates of $0.19.

Analysts are recommending an EPS of between -$0.31 and -$0.31 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.16, with 2 analysts recommending between $0.45 and -$0.77.

Revenue Estimates

According to 2 analysts, the current quarter’s revenue is expected to be $80.01M. It ranges from a high estimate of $80.92M to a low estimate of $79.1M. As of the current estimate, Cardlytics Inc.’s year-ago sales were $72.71M, an estimated increase of 10.00% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $98.4M, an increase of 19.30% over than the figure of $10.00% in the same quarter last year. There is a high estimate of $100.64M for the next quarter, whereas the lowest estimate is $96.16M.

A total of 2 analysts have provided revenue estimates for CDLX’s current fiscal year. The highest revenue estimate was $322.59M, while the lowest revenue estimate was $310.99M, resulting in an average revenue estimate of $316.79M. In the same quarter a year ago, actual revenue was $298.54M, up 6.10% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $362.63M in the next fiscal year. The high estimate is $375.56M and the low estimate is $349.7M. The average revenue growth estimate for next year is up 14.50% from the average revenue estimate for this year.


Please enter your comment!
Please enter your name here